Danimer Scientific, Inc. (DNMR) has disclosed a new risk, in the Accounting & Financial Operations category.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Danimer Scientific, Inc. faces significant business risks due to its negative cash flow and insufficient financial resources, casting doubt on its ability to continue operations. Despite projected revenue growth in 2025, the company lacks contracted revenues and adequate liquidity to sustain operations for the next twelve months. The company may need to raise additional capital through equity or debt, which could lead to shareholder dilution and uncertainty about its financial viability. Failure to secure financing could result in bankruptcy or asset liquidation, jeopardizing shareholder investments.
Overall, Wall Street has a Hold consensus rating on DNMR stock based on 1 Hold.
To learn more about Danimer Scientific, Inc.’s risk factors, click here.